It acts on specific receptors in the brain that regulate appetite and food intake, leading to a decreased desire to eat
16 , e2004122 (2018)
[1] FDA Warning Letter, Apothecary Pharma: December 1, 2025 [2] FDA Warning Letter, Hallandale Pharmacy: May 3, 2022 [3] FDA Warning Letters: Empower Pharmacy: May 2017, October 2021, April 2025 [4] OptioRx Chapter 11 Filing, Case 24-11188, June/July 2024 [5] BBB Profile, Lavender Sky Health LLC [6] Trustpilot Reviews, Lavender Sky Health Disclaimer: This review is for informational purposes only and does not constitute medical advice
E.ParkH
SAG via thioesterase hydrolysis) no metabolic competition
Mounjaro, which contains the active ingredient tirzepatide, also acts on a second hormone involved in appetite and blood sugar control